Nicotine Gum Market
Growth Factors of Nicotine Gum Market
The nicotine gum market size was valued at USD 1.63 billion in 2023, and the market is now projected to grow from USD 1.70 billion in 2024 to USD 2.55 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period of 2024-2032.
The COVID-19 pandemic around the world has been unestablished and the experiencing lesser demand than expected in all areas than in the pre-COVID period. According to the findings made, the global nicotine gum market growth trend showed a negative change of 4.19% reduction recorded in 2020 compared to 2019.
These anti-smoking campaigns are driving the nicotine gum market share through growing urbanization, novelty products and studies. Local and international governments, non-governmental organizations and stakeholders encourage the use of nicotine gums and other replacement therapies during tobacco quit attempts. They focus on young people in emerging as well as developed countries, improving quit ratios through effective product and program synergies.
However, one of the major factors which benefit the market is a growing concern over personal health and a transition towards healthier consumer habits. Governments of different countries are adopting tobacco control measures such as advertising restrictions, increased taxes, and smoking prohibitions in public places. Larger health warnings and more effective and intensive anti-smoking campaigns are persuading consumers to adopt non-tobacco products to avoid consuming tobacco in any form, thereby increasing the market for stop-smoking products.
Comprehensive Analysis of Nicotine Gum Market
Market segmentation has made the nicotine gum market and food and beverages industry grow exponentially. This market expansion offers a differentiated regional appraisal considering the supply and demand dynamics influencing the food supplements market. These segmentations are systematically sorted out according to types and distribution channels. The types include, 2mg, 4mg, and 6mg. However, the distribution channels include Supermarkets & Hypermarkets, Pharmacy and Online Channels.
North America’s market share is growing due to increasing awareness of health and initiatives taken by the government. Domestic and global firms uplift their competitive status by innovating to meet the increasing demand for major regional brands. For instance, Nicorette introduced nicotine gum coated with ice mint to the market in 2019. Such innovations are believed to impact the nicotine gum market throughout the study period positively.
The leading players influence the food & beverages industry by ensuring industrial prospectus growth and establishing market trends. These players include, GlaxoSmithKline plc (U.K.), Johnson & Johnson (U.S.), Novartis Consumer Health (Germany), ITC Limited (India), Cipla Health Limited (India), Perrigo Company Plc (Ireland), Fertin Pharma (Denmark), Alchem International (India) and Revolymer (U.K.). These market players offer a level-playing competitive environment.
In August 2023, Starface, a Gen Z pimple-focused skincare brand, created a new company called Blip that will sell nicotine gum and lozenges. Blip distributes its NRTs (Nicotine Replacement Therapy) both to its online customer base and at selected CVS locations across the U.S. Its main products are mainly targeting the millennial/NEXT Gen consumers with inventions such as retro-packaged Vista.
Segmentation Table
Global Nicotine Gum Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 5.1% from 2024 to 2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Type, Distribution Channel, and Region
By Type - 2 mg
- 4 mg
- 6 mg
By Distribution Channel - Supermarkets and Hypermarkets
- Pharmacies
- Online Stores
By Region - North America (By Type, By Distribution Channel, & By Country)
- U.S. (By Distribution Channel)
- Canada (By Distribution Channel)
- Mexico (By Distribution Channel)
- U.K. (By Distribution Channel)
- Germany (By Distribution Channel)
- France (By Distribution Channel)
- Italy (By Distribution Channel)
- Spain (By Distribution Channel)
- Russia (By Distribution Channel)
- Rest of Europe (By Distribution Channel)
- China (By Distribution Channel)
- India (By Distribution Channel)
- Australia (By Distribution Channel)
- Japan (By Distribution Channel)
- Rest of Asia- Pacific (By Distribution Channel)
- Brazil (By Distribution Channel)
- Argentina (By Distribution Channel)
- Rest of South America (By Distribution Channel)
- UAE (By Distribution Channel)
- South Africa (By Distribution Channel)
- Rest of the Middle East & Africa (By Distribution Channel)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Emerging Trends
- 4. Key Insights
- 4.1. Overview of the Parent/Related Markets
- 4.2. Industry SWOT Analysis
- 4.3. Supply Chain and Regulatory Analysis
- 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
- 4.5. Qualitative Analysis Related to COVID-19
- 4.5.1. Impact of COVID-19 on the Market
- 4.5.2. Supply Chain Challenges amidst Pandemic
- 4.5.3. Potential Opportunities due to this Global Crisis
- 5. Global Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Key Findings / Summary
- 5.2. Market Size Estimates and Forecast
- 5.2.1. By Type
- 5.2.1.1. 2 MG
- 5.2.1.2. 4 MG
- 5.2.1.3. Hymenoptera
- 5.2.1.4. Orthopetra
- 5.2.1.5. 6 MG
- 5.2.2. By Distribution Channel
- 5.2.2.1. Supermarkets & Hypermarkets
- 5.2.2.2. Pharmacy
- 5.2.2.3. Online Retail
- 5.2.3. By Region
- 5.2.3.1. North America
- 5.2.3.2. Europe
- 5.2.3.3. Asia Pacific
- 5.2.3.4. South America
- 5.2.3.5. Middle East & Africa
- 6. North America Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Key Findings / Summary
- 6.2. Market Size Estimates and Forecast
- 6.2.1. By Type
- 6.2.1.1. 2 MG
- 6.2.1.2. 4 MG
- 6.2.1.3. 6 MG
- 6.2.2. By Distribution Channel
- 6.2.2.1. Supermarkets & Hypermarkets
- 6.2.2.2. Pharmacy
- 6.2.2.3. Online Retail
- 6.2.3. By Country (Value)
- 6.2.3.1. U.S.
- 6.2.3.1.1. By Distribution Channel
- 6.2.3.1.1.1. Supermarkets & Hypermarkets
- 6.2.3.1.1.2. Pharmacy
- 6.2.3.1.1.3. Online Retail
- 6.2.3.2. Canada
- 6.2.3.2.1. By Distribution Channel
- 6.2.3.2.1.1. Supermarkets & Hypermarkets
- 6.2.3.2.1.2. Pharmacy
- 6.2.3.2.1.3. Online Retail
- 6.2.3.3. Mexico
- 6.2.3.3.1. By Distribution Channel
- 6.2.3.3.1.1. Supermarkets & Hypermarkets
- 6.2.3.3.1.2. Pharmacy
- 6.2.3.3.1.3. Online Retail
- 7. Europe Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Key Findings / Summary
- 7.2. Market Size Estimates and Forecast
- 7.2.1. By Type
- 7.2.1.1. 2 MG
- 7.2.1.2. 4 MG
- 7.2.1.3. 6 MG
- 7.2.2. By Distribution Channel
- 7.2.2.1. Supermarkets & Hypermarkets
- 7.2.2.2. Pharmacy
- 7.2.2.3. Online Retail
- 7.2.3. By Country (Value)
- 7.2.3.1. Germany
- 7.2.3.1.1. By Distribution Channel
- 7.2.3.1.1.1. Supermarkets & Hypermarkets
- 7.2.3.1.1.2. Pharmacy
- 7.2.3.1.1.3. Online Retail
- 7.2.3.2. France
- 7.2.3.2.1. By Distribution Channel
- 7.2.3.2.1.1. Supermarkets & Hypermarkets
- 7.2.3.2.1.2. Pharmacy
- 7.2.3.2.1.3. Online Retail
- 7.2.3.3. Italy
- 7.2.3.3.1. By Distribution Channel
- 7.2.3.3.1.1. Supermarkets & Hypermarkets
- 7.2.3.3.1.2. Pharmacy
- 7.2.3.3.1.3. Online Retail
- 7.2.3.4. U.K.
- 7.2.3.4.1. By Distribution Channel
- 7.2.3.4.1.1. Supermarkets & Hypermarkets
- 7.2.3.4.1.2. Pharmacy
- 7.2.3.4.1.3. Online Retail
- 7.2.3.5. Spain
- 7.2.3.5.1. By Distribution Channel
- 7.2.3.5.1.1. Supermarkets & Hypermarkets
- 7.2.3.5.1.2. Pharmacy
- 7.2.3.5.1.3. Online Retail
- 7.2.3.6. Rest of Europe
- 7.2.3.6.1. By Distribution Channel
- 7.2.3.6.1.1. Supermarkets & Hypermarkets
- 7.2.3.6.1.2. Pharmacy
- 7.2.3.6.1.3. Online Retail
- 8. Asia Pacific Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Key Findings / Summary
- 8.2. Market Size Estimates and Forecast
- 8.2.1. By Type
- 8.2.1.1. 2 MG
- 8.2.1.2. 4 MG
- 8.2.1.3. 6 MG
- 8.2.2. By Distribution Channel
- 8.2.2.1. Supermarkets & Hypermarkets
- 8.2.2.2. Pharmacy
- 8.2.2.3. Online Retail
- 8.2.3. By Country (Value)
- 8.2.3.1. China
- 8.2.3.1.1. By Distribution Channel
- 8.2.3.1.1.1. Supermarkets & Hypermarkets
- 8.2.3.1.1.2. Pharmacy
- 8.2.3.1.1.3. Online Retail
- 8.2.3.2. India
- 8.2.3.2.1. By Distribution Channel
- 8.2.3.2.1.1. Supermarkets & Hypermarkets
- 8.2.3.2.1.2. Pharmacy
- 8.2.3.2.1.3. Online Retail
- 8.2.3.3. Japan
- 8.2.3.3.1. By Distribution Channel
- 8.2.3.3.1.1. Supermarkets & Hypermarkets
- 8.2.3.3.1.2. Pharmacy
- 8.2.3.3.1.3. Online Retail
- 8.2.3.4. Australia
- 8.2.3.4.1. By Distribution Channel
- 8.2.3.4.1.1. Supermarkets & Hypermarkets
- 8.2.3.4.1.2. Pharmacy
- 8.2.3.4.1.3. Online Retail
- 8.2.3.5. Rest of Asia Pacific
- 8.2.3.5.1. By Distribution Channel
- 8.2.3.5.1.1. Supermarkets & Hypermarkets
- 8.2.3.5.1.2. Pharmacy
- 8.2.3.5.1.3. Online Retail
- 9. South America Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Key Findings / Summary
- 9.2. Market Size Estimates and Forecast
- 9.2.1. By Type
- 9.2.1.1. 2 MG
- 9.2.1.2. 4 MG
- 9.2.1.3. Hymenoptera
- 9.2.1.4. Orthopetra
- 9.2.1.5. 6 MG
- 9.2.2. By Distribution Channel
- 9.2.2.1. Supermarkets & Hypermarkets
- 9.2.2.2. Pharmacy
- 9.2.2.3. Online Retail
- 9.2.3. By Country (Value)
- 9.2.3.1. Brazil
- 9.2.3.1.1. By Distribution Channel
- 9.2.3.1.1.1. Supermarkets & Hypermarkets
- 9.2.3.1.1.2. Pharmacy
- 9.2.3.1.1.3. Online Retail
- 9.2.3.2. Argentina
- 9.2.3.2.1. By Distribution Channel
- 9.2.3.2.1.1. Supermarkets & Hypermarkets
- 9.2.3.2.1.2. Pharmacy
- 9.2.3.2.1.3. Online Retail
- 9.2.3.3. Rest of South America
- 9.2.3.3.1. By Distribution Channel
- 9.2.3.3.1.1. Supermarkets & Hypermarkets
- 9.2.3.3.1.2. Pharmacy
- 9.2.3.3.1.3. Online Retail
- 10. Middle East & Africa Nicotine Gum Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Key Findings / Summary
- 10.2. Market Size Estimates and Forecast
- 10.2.1. By Type
- 10.2.1.1. 2 MG
- 10.2.1.2. 4 MG
- 10.2.1.3. 6 MG
- 10.2.2. By Distribution Channel
- 10.2.2.1. Supermarkets & Hypermarkets
- 10.2.2.2. Pharmacy
- 10.2.2.3. Online Retail
- 10.2.3. By Country (Value)
- 10.2.3.1. South Africa
- 10.2.3.1.1. By Distribution Channel
- 10.2.3.1.1.1. Supermarkets & Hypermarkets
- 10.2.3.1.1.2. Pharmacy
- 10.2.3.1.1.3. Online Retail
- 10.2.3.2. UAE
- 10.2.3.2.1. By Distribution Channel
- 10.2.3.2.1.1. Supermarkets & Hypermarkets
- 10.2.3.2.1.2. Pharmacy
- 10.2.3.2.1.3. Online Retail
- 10.2.3.3. Rest of Middle East & Africa
- 10.2.3.3.1. By Distribution Channel
- 10.2.3.3.1.1. Supermarkets & Hypermarkets
- 10.2.3.3.1.2. Pharmacy
- 10.2.3.3.1.3. Online Retail
- 11. Competitive Matrix
- 11.1. Business Strategies Adopted by Leading Players
- 11.2. Global Nicotine Gum Market Revenue Share/Ranking Analysis, By Key Manufacturer
- 12. Company Profiles
- 12.1. GlaxoSmithKline plc
- 12.1.1. Overview
- 12.1.2. Description
- 12.1.3. Product Portfolio
- 12.1.4. Financials (Data as available in public domain and/or on paid databases)
- 12.1.5. Recent Developments
- 12.2. Novartis Consumer Health
- 12.2.1. Overview
- 12.2.2. Description
- 12.2.3. Product Portfolio
- 12.2.4. Financials (Data as available in public domain and/or on paid databases)
- 12.2.5. Recent Developments
- 12.3. ITC Limited
- 12.3.1. Overview
- 12.3.2. Description
- 12.3.3. Product Portfolio
- 12.3.4. Financials (Data as available in public domain and/or on paid databases)
- 12.3.5. Recent Developments
- 12.4. Johnson & Johnson
- 12.4.1. Overview
- 12.4.2. Description
- 12.4.3. Product Portfolio
- 12.4.4. Financials (Data as available in public domain and/or on paid databases)
- 12.4.5. Recent Developments
- 12.5. Novartis AG
- 12.5.1. Overview
- 12.5.2. Description
- 12.5.3. Product Portfolio
- 12.5.4. Financials (Data as available in public domain and/or on paid databases)
- 12.5.5. Recent Developments
- 12.6. Cipla Health Limited
- 12.6.1. Overview
- 12.6.2. Description
- 12.6.3. Product Portfolio
- 12.6.4. Financials (Data as available in public domain and/or on paid databases)
- 12.6.5. Recent Developments
- 12.7. Perrigo Company Plc
- 12.7.1. Overview
- 12.7.2. Description
- 12.7.3. Product Portfolio
- 12.7.4. Financials (Data as available in public domain and/or on paid databases)
- 12.7.5. Recent Developments
- 12.8. Fertin Pharma
- 12.8.1. Overview
- 12.8.2. Description
- 12.8.3. Product Portfolio
- 12.8.4. Financials (Data as available in public domain and/or on paid databases)
- 12.8.5. Recent Developments
- 12.9. Alchem International
- 12.9.1. Overview
- 12.9.2. Description
- 12.9.3. Product Portfolio
- 12.9.4. Financials (Data as available in public domain and/or on paid databases)
- 12.9.5. Recent Developments
- 12.10. Revolymer
- 12.10.1. Overview
- 12.10.2. Description
- 12.10.3. Product Portfolio
- 12.10.4. Financials (Data as available in public domain and/or on paid databases)
- 12.10.5. Recent Developments
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook